Bill

Bill > S3478


US S3478

Commission on America’s Medical Security Act


summary

Introduced
03/12/2020
In Committee
03/12/2020
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

A bill to require a report to assess, evaluate, and address the dependence of the United States on critical drugs and devices sourced or manufactured outside of the United States. This bill requires the Department of Health and Human Services to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to report on the security of the U.S. medical product supply chain (i.e., supply of drugs and devices). Among other things, the report shall assess the dependence of the United States, including the private sector, states, and federal government, on critical drugs and devices sourced or manufactured outside of the United States; and provide recommendations to address supply vulnerabilities or potential disruptions.

AI Summary

This bill requires the Department of Health and Human Services to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to report on the security of the U.S. medical product supply chain, including the dependence of the U.S. (private sector, states, and federal government) on critical drugs and devices sourced or manufactured outside of the U.S. The report shall provide recommendations to address supply vulnerabilities or potential disruptions, such as promoting supply chain redundancy and contingency planning, encouraging domestic manufacturing, improving supply chain information gaps, and improving planning considerations for medical product supply chain capacity during public health emergencies.

Committee Categories

Health and Social Services

Sponsors (12)

Last Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S1743) (on 03/12/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...